Phase I–II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma by Plummer, R, Lorigan, P, Brown, E, Zaucha, R, Moiseyenko, V, Demidov, L, Soriano, V, Chmielowska, E, Andrés, R, Kudryavtseva, G, Kahatt, C, Szyldergemajn, S, Extremera, S, de Miguel, B, Cullell-Young, M, Calvert, H

Get full text

A phase I pharmacokinetic study of PM00104 (Zalypsis®) administered as a 24-h intravenous infusion every 3 weeks in patients with advanced solid tumors by Capdevila, J., Clive, S., Casado, E., Michie, C., Piera, A., Sicart, E., Carreras, M. J., Coronado, C., Kahatt, C., Soto Matos-Pita, A., Fernandez Teruel, C., Siguero, M., Cullell-Young, M., Tabernero, J.

Get full text

Antitumor activity of lurbinectedin in combination with oral capecitabine in patients with metastatic breast cancer by Awada, A.H., Boni, V., Moreno, V., Aftimos, P., Kahatt, C., Luepke-Estefan, X.E., Siguero, M., Fernandez-Teruel, C., Cullell-Young, M., Tabernero, J.

Get full text

Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors by Salazar, R., Cortés-Funes, H., Casado, E., Pardo, B., López-Martín, A., Cuadra, C., Tabernero, J., Coronado, C., García, M., Soto Matos-Pita, A., Miguel-Lillo, B., Cullell-Young, M., Iglesias Dios, J. L., Paz-Ares, L.

Get full text

A phase I and pharmacokinetic study of elisidepsin (PM02734) in patients with advanced solid tumors by Salazar, R., Jones, R. J., Oaknin, A., Crawford, D., Cuadra, C., Hopkins, C., Gil, M., Coronado, C., Soto-Matos, A., Cullell-Young, M., Iglesias Dios, J. L., Evans, T. R. J.

Get full text

From transcription to cell surface expression, the induction of MHC class II I-A alpha by interferon-gamma in macrophages is regulated at different levels by Cullell-Young, M, Barrachina, M, López-López, C, Goñalons, E, Lloberas, J, Soler, C, Celada, A

Get full text

Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin’s lymphoma by Ribrag, Vincent, Caballero, Dolores, Fermé, Christophe, Zucca, Emanuele, Arranz, Reyes, Briones, Javier, Gisselbrecht, Christian, Salles, Gilles, Gianni, Alessandro M, Gomez, Henry, Kahatt, Carmen, Corrado, Claudia, Szyldergemajn, Sergio, Extremera, Sonia, de Miguel, Bernardo, Cullell-Young, Martin, Cavalli, Franco

Get full text

P2.12-13 Lurbinectedin (L) Combined with Paclitaxel (P) or Irinotecan (I) in Relapsed SCLC. Results from Two Phase Lb Trials by Ponce, S., Calvo, E., De Miguel, M.J., Sessa, C., Flor, M.J., Drilon, A., Falcon, A., Simon, I. Sanchez, Nuñez, R., Luepke, X.E., Cuevas-Melendez, N., López-Vilariño, J., Fudio, S., Siguero, M., Cullell-Young, M., Kahatt, C., Zeaiter, A., Paz-Ares, L.

Get full text

Phase I―II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma by PLUMMER, R, LORIGAN, P, KAHATT, C, SZYLDERGEMAJN, S, EXTREMERA, S, DE MIGUEL, B, CULLELL-YOUNG, M, CALVERT, H, BROWN, E, ZAUCHA, R, MOISEYENKO, V, DEMIDOV, L, SORIANO, V, CHMIELOWSKA, E, ANDRES, R, KUDRYAVTSEVA, G

Get full text